Loratin® Tablet: Each tablet contains Loratadine USP 10 mg.
Loratin® Suspension: Each 5 ml suspension contains Loratadine USP 5 mg.
Loratadine is not recommended for children under 2 years of age. Upon several weeks administration, Loratadine does not show any decreased activity.
When administered concurrently with alcohol, Loratadine has no potentiating effects as measured by psychomotor performance studies.
Loratadine should not be administered during pregnancy. There is no experience of the use of Loratadine in human pregnancy. In animal studies Loratadine was not teratogenic; at high doses some embryotoxic effects were observed. Pregnancy category B. Loratadine should be used during pregnancy only if clearly needed. Since Loratadine is excreted in breast milk, it should not be administered to lactating women.
Store in a cool, dry place and protect from sun light. Store the suspension below 30°C. Keep out of reach of children.
Loratin® Tablet: Box containing 10 x 10 tablets in blister pack. Loratin® Suspension: Each PET bottle contains 60 ml suspension and a measuring cup.